Technical Analysis for AMRN - Amarin Corporation plc
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.84 | -2.55% | -0.02 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Boomer Sell Setup | Bearish Swing Setup | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Inside Day | Range Contraction | -2.55% | |
Wide Bands | Range Expansion | -2.55% | |
Oversold Stochastic | Weakness | -2.55% | |
Reversal New Lows Setup | Bearish Swing Setup | 1.84% | |
Outside Day | Range Expansion | 1.84% |
Alert | Time |
---|---|
Possible NR7 | about 12 hours ago |
Possible Inside Day | about 12 hours ago |
60 Minute Opening Range Breakdown | about 15 hours ago |
Down 3% | about 15 hours ago |
Down 2 % | about 16 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/01/2024
Amarin Corporation plc Description
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Acid Organic Compounds Cardiovascular Disease Therapeutic Products Lipid Vascular Disease Nutrition Cholesterol Fatty Acids Lipoprotein Low Density Lipoprotein Triglyceride Hypertriglyceridemia Polyunsaturated Fat Saturated Fat Statin Therapy
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.6575 |
52 Week Low | 0.651 |
Average Volume | 2,395,807 |
200-Day Moving Average | 1.01 |
50-Day Moving Average | 1.11 |
20-Day Moving Average | 1.03 |
10-Day Moving Average | 0.89 |
Average True Range | 0.07 |
RSI (14) | 33.77 |
ADX | 30.51 |
+DI | 10.49 |
-DI | 28.88 |
Chandelier Exit (Long, 3 ATRs) | 1.14 |
Chandelier Exit (Short, 3 ATRs) | 1.02 |
Upper Bollinger Bands | 1.36 |
Lower Bollinger Band | 0.70 |
Percent B (%b) | 0.21 |
BandWidth | 64.23 |
MACD Line | -0.08 |
MACD Signal Line | -0.06 |
MACD Histogram | -0.0225 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.89 | ||||
Resistance 3 (R3) | 0.90 | 0.88 | 0.88 | ||
Resistance 2 (R2) | 0.88 | 0.86 | 0.88 | 0.88 | |
Resistance 1 (R1) | 0.86 | 0.85 | 0.85 | 0.86 | 0.88 |
Pivot Point | 0.84 | 0.84 | 0.84 | 0.84 | 0.84 |
Support 1 (S1) | 0.82 | 0.83 | 0.81 | 0.82 | 0.80 |
Support 2 (S2) | 0.80 | 0.82 | 0.80 | 0.79 | |
Support 3 (S3) | 0.78 | 0.80 | 0.79 | ||
Support 4 (S4) | 0.78 |